Europharma Research & Science Center Sp. z o.o. is a company in Poland, with a head office in Katowice. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Europharma Research & Science Center Sp. z o.o. was incorporated on February 01, 2007. The total number of employees is currently Above 250 (2014). The latest financial highlights indicate a net sales revenue increase of 38.7% in 2024. There was a total growth of 27.73% in Europharma Research & Science Center Sp. z o.o.’s total assets over the same period. The net profit margin of Europharma Research & Science Center Sp. z o.o. decreased by 6.3% in 2024.

Headquarters
Ul. Krzywa 6
Katowice; Slaskie; Postal Code: 40-061

Contact Details: Purchase the Europharma Research & Science Center Sp. z o.o. report to view the information.

Website: http://www.europharma.edu.pl

Basic Information

Total Employees:

Purchase the Europharma Research & Science Center Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Europharma Research & Science Center Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Europharma Research & Science Center Sp. z o.o. report to view the information.

Incorporation Date:

February 01, 2007

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

51%

Purchase this report to view the information.

49%

Company Performance

Financial values in the chart are available after Europharma Research & Science Center Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

38.7%▲

Total operating revenue

38.17%▲

Operating Profit/Loss (EBIT)

-61.14%▼

EBITDA

-61.02%▼

Net Profit/Loss for the Period

-63.9%▼

Total Assets

27.73%▲

Total Equity

7.31%▲

Operating Profit Margin (ROS)

-6.51%▼

Net Profit Margin

-6.3%▼

Return on Equity (ROE)

-13.44%▼

Quick Ratio

-0.46%▼

Europharma Research & Science Center Sp. z o.o. (Poland)